2 results
Approved WMOCompleted
Primary ObjectivesTo assess the safety of 2 fixed doses of EVP-6124 (2 or 3 mg daily) for up to 52 weeks in subjects withAlzheimer*s disease (AD) who complete (Day 182) studies EVP-6124-024 or EVP-6124-025Secondary ObjectivesTo assess the duration…
Approved WMORecruiting
The overall aim of this study is to gain insight into the pathophysiological mechanisms behind cervical radiculopathy and determine if conservative treatment targets these processes. Different research questions are formulated:1) Is there any…